BARINTHUS BIOTHERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 1.99 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 836.17K shares, a 34.96% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 1.16M shares, a 191.75% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 233.82K shares, a 10.84% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 915.52K shares, a 113.37% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 2.17M shares, a 135.21% increase from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 920.76K shares, a 3.12% increase from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 892.91K shares, a 117.39% increase from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 410.74K shares, a 233.71% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 836.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.99M shares 10-Q · filed 2026-08-06 | 2.23M shares derived: sum of 3 quarters · filed 2026-08-06 | 3.14M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.16M shares 10-Q · filed 2026-04-30 | 1.39M shares derived: sum of 2 quarters · filed 2026-04-30 | 2.31M shares derived: sum of 3 quarters · filed 2026-04-30 | 2.93M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 233.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 1.15M shares derived: sum of 2 quarters · filed 2026-03-13 | 1.77M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.17M shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 915.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 1.54M shares derived: sum of 2 quarters · filed 2026-08-06 | 1.93M shares 10-Q · filed 2025-11-07 | 2.19M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 619.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.02M shares 10-Q · filed 2026-08-06 | 1.28M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.71M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 396.81K shares 10-Q · filed 2026-04-30 | 659.05K shares derived: sum of 2 quarters · filed 2026-04-30 | 1.09M shares derived: sum of 3 quarters · filed 2026-04-30 | 1.25M shares derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 262.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 691.33K shares derived: sum of 2 quarters · filed 2025-11-07 | 849.81K shares derived: sum of 3 quarters · filed 2025-11-07 | 920.76K shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 429.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 587.57K shares derived: sum of 2 quarters · filed 2025-11-07 | 658.51K shares 10-Q · filed 2025-11-07 | 886.97K shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | 158.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 229.43K shares 10-Q · filed 2025-08-07 | 457.89K shares derived: sum of 3 quarters · filed 2025-08-07 | 904.48K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 70.95K shares 10-Q · filed 2025-05-07 | 299.40K shares derived: sum of 2 quarters · filed 2025-05-07 | 745.99K shares derived: sum of 3 quarters · filed 2025-05-07 | 905.88K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 228.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 675.05K shares derived: sum of 2 quarters · filed 2024-11-06 | 834.94K shares derived: sum of 3 quarters · filed 2024-11-06 | 892.91K shares 10-K · filed 2024-03-20 |
| 2023-09-30 | 446.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 606.48K shares derived: sum of 2 quarters · filed 2024-11-06 | 664.45K shares 10-Q · filed 2024-11-06 | |
| 2023-06-30 | 159.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 217.86K shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 57.97K shares 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | 410.74K shares 10-K · filed 2023-03-24 | |||
| 2021-12-31 | 123.08K shares 10-K · filed 2022-03-25 |